nodes	percent_of_prediction	percent_of_DWPC	metapath
Paroxetine—CHRM1—schizophrenia	0.232	0.304	CbGaD
Paroxetine—SLC6A3—schizophrenia	0.165	0.216	CbGaD
Paroxetine—SLC6A4—schizophrenia	0.123	0.161	CbGaD
Paroxetine—HTR2A—schizophrenia	0.0946	0.124	CbGaD
Paroxetine—CYP2D6—schizophrenia	0.0865	0.113	CbGaD
Paroxetine—ABCB1—schizophrenia	0.0618	0.081	CbGaD
Paroxetine—SLC6A2—locus ceruleus—schizophrenia	0.00579	0.0715	CbGeAlD
Paroxetine—HTR2A—locus ceruleus—schizophrenia	0.00348	0.043	CbGeAlD
Paroxetine—SLC6A3—telencephalic ventricle—schizophrenia	0.0034	0.042	CbGeAlD
Paroxetine—SLC6A2—autonomic nervous system—schizophrenia	0.00308	0.038	CbGeAlD
Paroxetine—HTR2A—cerebellar cortex—schizophrenia	0.00284	0.035	CbGeAlD
Paroxetine—HTR2A—pons—schizophrenia	0.002	0.0248	CbGeAlD
Paroxetine—HTR2A—autonomic nervous system—schizophrenia	0.00185	0.0228	CbGeAlD
Paroxetine—CYP2C9—urine—schizophrenia	0.00183	0.0226	CbGeAlD
Paroxetine—TACR1—forebrain—schizophrenia	0.00177	0.0218	CbGeAlD
Paroxetine—HTR2A—telencephalic ventricle—schizophrenia	0.00165	0.0204	CbGeAlD
Paroxetine—TACR1—telencephalon—schizophrenia	0.00162	0.0201	CbGeAlD
Paroxetine—HTR2A—urine—schizophrenia	0.00151	0.0186	CbGeAlD
Paroxetine—SLC6A4—blood plasma—schizophrenia	0.00149	0.0184	CbGeAlD
Paroxetine—HTR2A—pineal body—schizophrenia	0.00143	0.0177	CbGeAlD
Paroxetine—CYP2D6—urine—schizophrenia	0.00137	0.017	CbGeAlD
Paroxetine—TACR1—blood—schizophrenia	0.00118	0.0146	CbGeAlD
Paroxetine—CYP2C8—blood plasma—schizophrenia	0.00107	0.0133	CbGeAlD
Paroxetine—TACR1—endocrine gland—schizophrenia	0.00102	0.0127	CbGeAlD
Paroxetine—CYP2B6—blood plasma—schizophrenia	0.000964	0.0119	CbGeAlD
Paroxetine—TACR1—nervous system—schizophrenia	0.000959	0.0118	CbGeAlD
Paroxetine—CYP2C9—blood plasma—schizophrenia	0.000955	0.0118	CbGeAlD
Paroxetine—TACR1—central nervous system—schizophrenia	0.000923	0.0114	CbGeAlD
Paroxetine—CHRM4—nervous system—schizophrenia	0.000902	0.0111	CbGeAlD
Paroxetine—CHRM2—forebrain—schizophrenia	0.000891	0.011	CbGeAlD
Paroxetine—SLC6A3—forebrain—schizophrenia	0.000888	0.011	CbGeAlD
Paroxetine—CHRM4—central nervous system—schizophrenia	0.000868	0.0107	CbGeAlD
Paroxetine—CHRM2—telencephalon—schizophrenia	0.000819	0.0101	CbGeAlD
Paroxetine—SLC6A3—telencephalon—schizophrenia	0.000817	0.0101	CbGeAlD
Paroxetine—SLC6A4—forebrain—schizophrenia	0.000814	0.0101	CbGeAlD
Paroxetine—CHRM1—forebrain—schizophrenia	0.000811	0.01	CbGeAlD
Paroxetine—HTR2A—blood plasma—schizophrenia	0.000786	0.00971	CbGeAlD
Paroxetine—SLC6A4—telencephalon—schizophrenia	0.000749	0.00925	CbGeAlD
Paroxetine—CHRM1—telencephalon—schizophrenia	0.000746	0.00921	CbGeAlD
Paroxetine—TACR1—brain—schizophrenia	0.000733	0.00905	CbGeAlD
Paroxetine—CHRM3—forebrain—schizophrenia	0.000726	0.00896	CbGeAlD
Paroxetine—SLC6A2—forebrain—schizophrenia	0.000717	0.00885	CbGeAlD
Paroxetine—CYP2D6—blood plasma—schizophrenia	0.000716	0.00885	CbGeAlD
Paroxetine—CHRM5—nervous system—schizophrenia	0.000705	0.0087	CbGeAlD
Paroxetine—CHRM4—brain—schizophrenia	0.000689	0.00851	CbGeAlD
Paroxetine—CHRM5—central nervous system—schizophrenia	0.000678	0.00838	CbGeAlD
Paroxetine—CHRM3—telencephalon—schizophrenia	0.000667	0.00824	CbGeAlD
Paroxetine—SLC6A2—telencephalon—schizophrenia	0.000659	0.00814	CbGeAlD
Paroxetine—SLC6A3—midbrain—schizophrenia	0.000587	0.00725	CbGeAlD
Paroxetine—SLC6A2—gonad—schizophrenia	0.00055	0.00679	CbGeAlD
Paroxetine—SLC6A4—blood—schizophrenia	0.000544	0.00672	CbGeAlD
Paroxetine—CHRM5—brain—schizophrenia	0.000539	0.00665	CbGeAlD
Paroxetine—SLC6A4—midbrain—schizophrenia	0.000538	0.00664	CbGeAlD
Paroxetine—CHRM2—endocrine gland—schizophrenia	0.000517	0.00638	CbGeAlD
Paroxetine—ABCB1—blood plasma—schizophrenia	0.000515	0.00636	CbGeAlD
Paroxetine—CHRM2—nervous system—schizophrenia	0.000484	0.00597	CbGeAlD
Paroxetine—SLC6A3—nervous system—schizophrenia	0.000482	0.00596	CbGeAlD
Paroxetine—SLC6A4—endocrine gland—schizophrenia	0.000472	0.00583	CbGeAlD
Paroxetine—CHRM1—endocrine gland—schizophrenia	0.00047	0.00581	CbGeAlD
Paroxetine—CHRM2—central nervous system—schizophrenia	0.000466	0.00575	CbGeAlD
Paroxetine—SLC6A3—central nervous system—schizophrenia	0.000464	0.00574	CbGeAlD
Paroxetine—SLC6A3—cerebellum—schizophrenia	0.000454	0.00561	CbGeAlD
Paroxetine—SLC6A4—nervous system—schizophrenia	0.000442	0.00546	CbGeAlD
Paroxetine—CHRM1—nervous system—schizophrenia	0.00044	0.00544	CbGeAlD
Paroxetine—HTR2A—forebrain—schizophrenia	0.000431	0.00532	CbGeAlD
Paroxetine—SLC6A4—central nervous system—schizophrenia	0.000426	0.00526	CbGeAlD
Paroxetine—CHRM1—central nervous system—schizophrenia	0.000424	0.00524	CbGeAlD
Paroxetine—CHRM3—endocrine gland—schizophrenia	0.000421	0.0052	CbGeAlD
Paroxetine—SLC6A2—endocrine gland—schizophrenia	0.000416	0.00513	CbGeAlD
Paroxetine—CYP2B6—gonad—schizophrenia	0.000405	0.00501	CbGeAlD
Paroxetine—HTR2A—telencephalon—schizophrenia	0.000396	0.00489	CbGeAlD
Paroxetine—CHRM3—nervous system—schizophrenia	0.000394	0.00487	CbGeAlD
Paroxetine—CYP2C8—blood—schizophrenia	0.000394	0.00486	CbGeAlD
Paroxetine—CYP2D6—forebrain—schizophrenia	0.000392	0.00485	CbGeAlD
Paroxetine—SLC6A2—nervous system—schizophrenia	0.000389	0.00481	CbGeAlD
Paroxetine—CHRM3—central nervous system—schizophrenia	0.000379	0.00469	CbGeAlD
Paroxetine—SLC6A2—central nervous system—schizophrenia	0.000375	0.00463	CbGeAlD
Paroxetine—CHRM2—brain—schizophrenia	0.00037	0.00457	CbGeAlD
Paroxetine—SLC6A3—brain—schizophrenia	0.000369	0.00455	CbGeAlD
Paroxetine—CYP2D6—telencephalon—schizophrenia	0.000361	0.00446	CbGeAlD
Paroxetine—CYP2B6—blood—schizophrenia	0.000353	0.00436	CbGeAlD
Paroxetine—CYP2C9—blood—schizophrenia	0.00035	0.00432	CbGeAlD
Paroxetine—CYP2C8—endocrine gland—schizophrenia	0.000342	0.00422	CbGeAlD
Paroxetine—SLC6A4—brain—schizophrenia	0.000338	0.00417	CbGeAlD
Paroxetine—CHRM1—brain—schizophrenia	0.000337	0.00416	CbGeAlD
Paroxetine—HTR2A—gonad—schizophrenia	0.000331	0.00408	CbGeAlD
Paroxetine—CYP2B6—endocrine gland—schizophrenia	0.000306	0.00378	CbGeAlD
Paroxetine—CYP2C9—endocrine gland—schizophrenia	0.000303	0.00375	CbGeAlD
Paroxetine—CHRM3—brain—schizophrenia	0.000301	0.00372	CbGeAlD
Paroxetine—SLC6A2—brain—schizophrenia	0.000297	0.00367	CbGeAlD
Paroxetine—HTR2A—blood—schizophrenia	0.000288	0.00356	CbGeAlD
Paroxetine—CYP2B6—nervous system—schizophrenia	0.000287	0.00354	CbGeAlD
Paroxetine—HTR2A—midbrain—schizophrenia	0.000284	0.00351	CbGeAlD
Paroxetine—ABCB1—forebrain—schizophrenia	0.000282	0.00349	CbGeAlD
Paroxetine—CYP2B6—central nervous system—schizophrenia	0.000276	0.00341	CbGeAlD
Paroxetine—CYP2D6—blood—schizophrenia	0.000262	0.00324	CbGeAlD
Paroxetine—ABCB1—telencephalon—schizophrenia	0.00026	0.00321	CbGeAlD
Paroxetine—HTR2A—endocrine gland—schizophrenia	0.00025	0.00309	CbGeAlD
Paroxetine—CYP2C8—brain—schizophrenia	0.000244	0.00302	CbGeAlD
Paroxetine—HTR2A—nervous system—schizophrenia	0.000234	0.00289	CbGeAlD
Paroxetine—CYP2D6—endocrine gland—schizophrenia	0.000228	0.00281	CbGeAlD
Paroxetine—HTR2A—central nervous system—schizophrenia	0.000225	0.00278	CbGeAlD
Paroxetine—HTR2A—cerebellum—schizophrenia	0.00022	0.00272	CbGeAlD
Paroxetine—CYP2B6—brain—schizophrenia	0.000219	0.00271	CbGeAlD
Paroxetine—ABCB1—gonad—schizophrenia	0.000217	0.00268	CbGeAlD
Paroxetine—CYP2D6—nervous system—schizophrenia	0.000213	0.00263	CbGeAlD
Paroxetine—CYP2D6—central nervous system—schizophrenia	0.000205	0.00253	CbGeAlD
Paroxetine—CYP2D6—cerebellum—schizophrenia	0.0002	0.00248	CbGeAlD
Paroxetine—ABCB1—blood—schizophrenia	0.000189	0.00233	CbGeAlD
Paroxetine—ABCB1—midbrain—schizophrenia	0.000186	0.0023	CbGeAlD
Paroxetine—HTR2A—brain—schizophrenia	0.000179	0.00221	CbGeAlD
Paroxetine—ABCB1—endocrine gland—schizophrenia	0.000164	0.00202	CbGeAlD
Paroxetine—CYP2D6—brain—schizophrenia	0.000163	0.00201	CbGeAlD
Paroxetine—ABCB1—nervous system—schizophrenia	0.000153	0.00189	CbGeAlD
Paroxetine—ABCB1—central nervous system—schizophrenia	0.000148	0.00182	CbGeAlD
Paroxetine—ABCB1—cerebellum—schizophrenia	0.000144	0.00178	CbGeAlD
Paroxetine—ABCB1—brain—schizophrenia	0.000117	0.00145	CbGeAlD
Paroxetine—CHRM2—Signaling Pathways—HTR1A—schizophrenia	7.46e-06	4.77e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—NPS—schizophrenia	7.45e-06	4.76e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—NPS—schizophrenia	7.42e-06	4.74e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—NRG1—schizophrenia	7.37e-06	4.71e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—NPS—schizophrenia	7.35e-06	4.7e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—DRD1—schizophrenia	7.34e-06	4.69e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—HTR2C—schizophrenia	7.34e-06	4.69e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—MEF2C—schizophrenia	7.3e-06	4.67e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—HTR2C—schizophrenia	7.3e-06	4.67e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—DRD1—schizophrenia	7.3e-06	4.67e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—HTR2C—schizophrenia	7.28e-06	4.65e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—DRD1—schizophrenia	7.28e-06	4.65e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—CACNA1C—schizophrenia	7.25e-06	4.63e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—DRD1—schizophrenia	7.21e-06	4.61e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—HTR2C—schizophrenia	7.21e-06	4.61e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—PLA2G4A—schizophrenia	7.19e-06	4.59e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—GAPDH—schizophrenia	7.16e-06	4.57e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—NTRK2—schizophrenia	7.14e-06	4.56e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—DRD3—schizophrenia	7.11e-06	4.54e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—NTRK2—schizophrenia	7.1e-06	4.54e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—CLOCK—schizophrenia	7.09e-06	4.53e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—NTRK2—schizophrenia	7.08e-06	4.52e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—DRD3—schizophrenia	7.07e-06	4.52e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—PIK3C2A—schizophrenia	7.07e-06	4.52e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—YWHAZ—schizophrenia	7.06e-06	4.51e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—NRG1—schizophrenia	7.06e-06	4.51e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—DRD3—schizophrenia	7.05e-06	4.5e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—NTRK2—schizophrenia	7.01e-06	4.48e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—MEF2C—schizophrenia	6.99e-06	4.47e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—DRD3—schizophrenia	6.98e-06	4.46e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—TPH2—schizophrenia	6.91e-06	4.41e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—CACNB2—schizophrenia	6.91e-06	4.41e-05	CbGpPWpGaD
Paroxetine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—schizophrenia	6.91e-06	4.41e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—ERBB3—schizophrenia	6.9e-06	4.41e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—DRD4—schizophrenia	6.9e-06	4.41e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—DRD4—schizophrenia	6.87e-06	4.39e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—DRD4—schizophrenia	6.84e-06	4.37e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—DPYD—schizophrenia	6.8e-06	4.34e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—DRD4—schizophrenia	6.78e-06	4.33e-05	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—CYP1A2—schizophrenia	6.77e-06	4.33e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—YWHAZ—schizophrenia	6.76e-06	4.32e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—GAPDH—schizophrenia	6.74e-06	4.31e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—GAPDH—schizophrenia	6.68e-06	4.27e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—CLOCK—schizophrenia	6.68e-06	4.27e-05	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—TH—schizophrenia	6.68e-06	4.27e-05	CbGpPWpGaD
Paroxetine—ABCB1—Transmembrane transport of small molecules—APOA1—schizophrenia	6.65e-06	4.25e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—HTR2A—schizophrenia	6.64e-06	4.25e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—CLOCK—schizophrenia	6.62e-06	4.23e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—ERBB3—schizophrenia	6.61e-06	4.22e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—schizophrenia	6.61e-06	4.22e-05	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—COMT—schizophrenia	6.6e-06	4.22e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—CNR1—schizophrenia	6.59e-06	4.21e-05	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—GSTP1—schizophrenia	6.57e-06	4.2e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—CNR1—schizophrenia	6.56e-06	4.19e-05	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—MAOA—schizophrenia	6.55e-06	4.19e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—CNR1—schizophrenia	6.54e-06	4.18e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—schizophrenia	6.53e-06	4.17e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—TPH2—schizophrenia	6.51e-06	4.16e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—CACNB2—schizophrenia	6.51e-06	4.16e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—CNR1—schizophrenia	6.47e-06	4.14e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—TPH2—schizophrenia	6.46e-06	4.12e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—CACNB2—schizophrenia	6.46e-06	4.12e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—HTR7—schizophrenia	6.43e-06	4.11e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—DRD2—schizophrenia	6.43e-06	4.11e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—DPYD—schizophrenia	6.41e-06	4.09e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—HTR7—schizophrenia	6.4e-06	4.09e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—DRD2—schizophrenia	6.4e-06	4.09e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—DRD2—schizophrenia	6.38e-06	4.07e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—HTR7—schizophrenia	6.38e-06	4.07e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—HTR2A—schizophrenia	6.36e-06	4.07e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—DPYD—schizophrenia	6.35e-06	4.06e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—SNAP25—schizophrenia	6.34e-06	4.05e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—CYP2D6—schizophrenia	6.34e-06	4.05e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—CACNA1C—schizophrenia	6.32e-06	4.04e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—HTR7—schizophrenia	6.31e-06	4.03e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—DRD2—schizophrenia	6.31e-06	4.03e-05	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—ABCB1—schizophrenia	6.22e-06	3.97e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—APOE—schizophrenia	6.18e-06	3.95e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—PIK3C2A—schizophrenia	6.16e-06	3.94e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—APOA1—schizophrenia	6.11e-06	3.9e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—PRL—schizophrenia	6.07e-06	3.88e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—PRL—schizophrenia	6.04e-06	3.86e-05	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—PLA2G4A—schizophrenia	6.03e-06	3.86e-05	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—GSTM1—schizophrenia	6.03e-06	3.86e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—PRL—schizophrenia	6.02e-06	3.85e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—PRL—schizophrenia	5.96e-06	3.81e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—CACNA1C—schizophrenia	5.96e-06	3.81e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—APOE—schizophrenia	5.92e-06	3.78e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—CACNA1C—schizophrenia	5.9e-06	3.77e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—ESR1—schizophrenia	5.9e-06	3.77e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—APOA1—schizophrenia	5.85e-06	3.74e-05	CbGpPWpGaD
Paroxetine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—schizophrenia	5.83e-06	3.73e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—PIK3C2A—schizophrenia	5.8e-06	3.71e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—PIK3C2A—schizophrenia	5.75e-06	3.68e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—CYP1A2—schizophrenia	5.73e-06	3.66e-05	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—COMT—schizophrenia	5.68e-06	3.63e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—S100B—schizophrenia	5.66e-06	3.62e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—TH—schizophrenia	5.65e-06	3.61e-05	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—GSTP1—schizophrenia	5.65e-06	3.61e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—ESR1—schizophrenia	5.65e-06	3.61e-05	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—MAOA—schizophrenia	5.64e-06	3.6e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—S100B—schizophrenia	5.63e-06	3.6e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—S100B—schizophrenia	5.61e-06	3.59e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—S100B—schizophrenia	5.56e-06	3.55e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—CYP2D6—schizophrenia	5.52e-06	3.53e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—SNAP25—schizophrenia	5.52e-06	3.53e-05	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—TP53—schizophrenia	5.49e-06	3.51e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—ERBB4—schizophrenia	5.41e-06	3.46e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—ERBB4—schizophrenia	5.38e-06	3.44e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—ERBB4—schizophrenia	5.37e-06	3.43e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—GSK3B—schizophrenia	5.35e-06	3.42e-05	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—ABCB1—schizophrenia	5.35e-06	3.42e-05	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—MTHFR—schizophrenia	5.33e-06	3.41e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—ERBB4—schizophrenia	5.32e-06	3.4e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—SNAP25—schizophrenia	5.21e-06	3.33e-05	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—PLA2G4A—schizophrenia	5.19e-06	3.32e-05	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—GSTM1—schizophrenia	5.19e-06	3.32e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—CYP2D6—schizophrenia	5.16e-06	3.3e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—SNAP25—schizophrenia	5.16e-06	3.3e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—GSK3B—schizophrenia	5.12e-06	3.27e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—PLA2G4A—schizophrenia	5.09e-06	3.25e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—PLA2G4A—schizophrenia	5.06e-06	3.23e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—PLA2G4A—schizophrenia	5.05e-06	3.22e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—PLA2G4A—schizophrenia	5e-06	3.19e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—CYP1A2—schizophrenia	5e-06	3.19e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—NRG1—schizophrenia	5e-06	3.19e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—NRG1—schizophrenia	4.97e-06	3.17e-05	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—APOE—schizophrenia	4.97e-06	3.17e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—NRG1—schizophrenia	4.95e-06	3.16e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—MEF2C—schizophrenia	4.95e-06	3.16e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—MEF2C—schizophrenia	4.92e-06	3.15e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—TH—schizophrenia	4.92e-06	3.15e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—MEF2C—schizophrenia	4.91e-06	3.14e-05	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—APOA1—schizophrenia	4.91e-06	3.14e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—NRG1—schizophrenia	4.91e-06	3.13e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—MEF2C—schizophrenia	4.86e-06	3.11e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—COMT—schizophrenia	4.81e-06	3.07e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—YWHAZ—schizophrenia	4.79e-06	3.06e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—GSTP1—schizophrenia	4.78e-06	3.06e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—MAOA—schizophrenia	4.77e-06	3.05e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—YWHAZ—schizophrenia	4.76e-06	3.04e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—YWHAZ—schizophrenia	4.74e-06	3.03e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—CYP1A2—schizophrenia	4.71e-06	3.01e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—YWHAZ—schizophrenia	4.7e-06	3e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—ERBB3—schizophrenia	4.68e-06	2.99e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—CYP1A2—schizophrenia	4.67e-06	2.98e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—ERBB3—schizophrenia	4.65e-06	2.97e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—ERBB3—schizophrenia	4.64e-06	2.96e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—TH—schizophrenia	4.64e-06	2.96e-05	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—AKT1—schizophrenia	4.63e-06	2.96e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—schizophrenia	4.63e-06	2.96e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—TH—schizophrenia	4.6e-06	2.94e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—ERBB3—schizophrenia	4.6e-06	2.94e-05	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—MTHFR—schizophrenia	4.59e-06	2.93e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—ABCB1—schizophrenia	4.53e-06	2.89e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—HTR2A—schizophrenia	4.48e-06	2.86e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—HTR2A—schizophrenia	4.47e-06	2.85e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—HTR2A—schizophrenia	4.42e-06	2.83e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—PLA2G4A—schizophrenia	4.4e-06	2.81e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—GSTM1—schizophrenia	4.4e-06	2.81e-05	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—APOE—schizophrenia	4.27e-06	2.73e-05	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—APOA1—schizophrenia	4.22e-06	2.7e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—APOE—schizophrenia	4.19e-06	2.68e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—COMT—schizophrenia	4.19e-06	2.67e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—GSTP1—schizophrenia	4.17e-06	2.66e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—APOE—schizophrenia	4.17e-06	2.66e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—MAOA—schizophrenia	4.16e-06	2.66e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—APOE—schizophrenia	4.15e-06	2.65e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—APOA1—schizophrenia	4.14e-06	2.64e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—APOA1—schizophrenia	4.12e-06	2.63e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—APOE—schizophrenia	4.11e-06	2.63e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—APOA1—schizophrenia	4.1e-06	2.62e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—APOA1—schizophrenia	4.06e-06	2.6e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—ESR1—schizophrenia	4e-06	2.55e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—ESR1—schizophrenia	3.98e-06	2.54e-05	CbGpPWpGaD
Paroxetine—CHRM4—GPCR downstream signaling—AKT1—schizophrenia	3.97e-06	2.53e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—ESR1—schizophrenia	3.96e-06	2.53e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—COMT—schizophrenia	3.95e-06	2.52e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—GSTP1—schizophrenia	3.93e-06	2.51e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—ESR1—schizophrenia	3.93e-06	2.51e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—MAOA—schizophrenia	3.92e-06	2.5e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—COMT—schizophrenia	3.91e-06	2.5e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—GSTP1—schizophrenia	3.89e-06	2.49e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—MTHFR—schizophrenia	3.88e-06	2.48e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—MAOA—schizophrenia	3.88e-06	2.48e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—PLA2G4A—schizophrenia	3.83e-06	2.45e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—GSTM1—schizophrenia	3.83e-06	2.45e-05	CbGpPWpGaD
Paroxetine—CHRM5—GPCR downstream signaling—AKT1—schizophrenia	3.8e-06	2.43e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—schizophrenia	3.77e-06	2.41e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—ABCB1—schizophrenia	3.72e-06	2.37e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—ABCB1—schizophrenia	3.68e-06	2.35e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—GSK3B—schizophrenia	3.63e-06	2.32e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—APOE—schizophrenia	3.62e-06	2.31e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—PLA2G4A—schizophrenia	3.61e-06	2.31e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—GSTM1—schizophrenia	3.61e-06	2.31e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—GSK3B—schizophrenia	3.61e-06	2.3e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling by GPCR—AKT1—schizophrenia	3.6e-06	2.3e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—GSK3B—schizophrenia	3.6e-06	2.3e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—PLA2G4A—schizophrenia	3.58e-06	2.29e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—GSTM1—schizophrenia	3.58e-06	2.29e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—APOA1—schizophrenia	3.57e-06	2.28e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—GSK3B—schizophrenia	3.56e-06	2.27e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—EP300—schizophrenia	3.52e-06	2.25e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling by GPCR—AKT1—schizophrenia	3.45e-06	2.2e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—MTHFR—schizophrenia	3.38e-06	2.16e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—EP300—schizophrenia	3.37e-06	2.15e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—MTHFR—schizophrenia	3.19e-06	2.04e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—MTHFR—schizophrenia	3.16e-06	2.02e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—APOE—schizophrenia	3.15e-06	2.01e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—APOA1—schizophrenia	3.11e-06	1.99e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—APOE—schizophrenia	2.97e-06	1.9e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—APOE—schizophrenia	2.94e-06	1.88e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—APOA1—schizophrenia	2.93e-06	1.88e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—APOA1—schizophrenia	2.91e-06	1.86e-05	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—EP300—schizophrenia	2.83e-06	1.81e-05	CbGpPWpGaD
Paroxetine—HTR2A—GPCR downstream signaling—AKT1—schizophrenia	2.69e-06	1.72e-05	CbGpPWpGaD
Paroxetine—CHRM1—GPCR downstream signaling—AKT1—schizophrenia	2.67e-06	1.71e-05	CbGpPWpGaD
Paroxetine—CHRM3—GPCR downstream signaling—AKT1—schizophrenia	2.67e-06	1.7e-05	CbGpPWpGaD
Paroxetine—CHRM2—GPCR downstream signaling—AKT1—schizophrenia	2.64e-06	1.69e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—TP53—schizophrenia	2.52e-06	1.61e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—AKT1—schizophrenia	2.44e-06	1.56e-05	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—EP300—schizophrenia	2.43e-06	1.56e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—AKT1—schizophrenia	2.43e-06	1.55e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—AKT1—schizophrenia	2.42e-06	1.55e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—TP53—schizophrenia	2.41e-06	1.54e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—AKT1—schizophrenia	2.4e-06	1.53e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—EP300—schizophrenia	2.39e-06	1.52e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—EP300—schizophrenia	2.37e-06	1.52e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—EP300—schizophrenia	2.37e-06	1.51e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—EP300—schizophrenia	2.34e-06	1.5e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—AKT1—schizophrenia	2.13e-06	1.36e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—EP300—schizophrenia	2.06e-06	1.32e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—AKT1—schizophrenia	2.04e-06	1.3e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—EP300—schizophrenia	1.8e-06	1.15e-05	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—AKT1—schizophrenia	1.71e-06	1.09e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—TP53—schizophrenia	1.71e-06	1.09e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—TP53—schizophrenia	1.7e-06	1.09e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—TP53—schizophrenia	1.69e-06	1.08e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—EP300—schizophrenia	1.69e-06	1.08e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—EP300—schizophrenia	1.68e-06	1.07e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—TP53—schizophrenia	1.68e-06	1.07e-05	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—AKT1—schizophrenia	1.47e-06	9.4e-06	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—AKT1—schizophrenia	1.44e-06	9.21e-06	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—AKT1—schizophrenia	1.43e-06	9.16e-06	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—AKT1—schizophrenia	1.43e-06	9.13e-06	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—AKT1—schizophrenia	1.42e-06	9.05e-06	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—AKT1—schizophrenia	1.25e-06	7.96e-06	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—AKT1—schizophrenia	1.08e-06	6.93e-06	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—AKT1—schizophrenia	1.02e-06	6.53e-06	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—AKT1—schizophrenia	1.01e-06	6.48e-06	CbGpPWpGaD
